並列摘要
Over the past decades, despite advanced progress in research and medical, acute kidney injury is still associated with significant morbidity and mortality. Traditional diagnostic criteria of acute kidney injury is based on serum creatinine, which is not a reliable indicator during acute changes of kidney function. Novel biomarkers such as NGAL, KIM-1, IL-18 and cystatin C allow us to unravel the complex pathophysiology of acute kidney injury, and more importantly, to provide the chance of early diagnosis and timely treatment.
延伸閱讀
- 郭錦輯、蔡敦仁（2009）。急性腎損傷。當代醫學，(431)，681-685。https://doi.org/10.29941/MT.200909.0004
- 吳軍毅（2020）。顯影劑相關的急性腎損傷。腎臟與透析，32(1)，6-10。https://doi.org/10.6340/KD.202003_32(1).0002
- 李柏葒、陳昶旭、吳培甄、趙家德、楊光華、吳允升、台大急性腎損傷研究群（NSARF）（2011）。急性腎損傷生物標記。當代醫學，(449)，222-233。https://doi.org/10.29941/MT.201103.0014
- Huang, C. C., Lee, C. C., Chang, C. H., Chen, J. J., Yen, C. L., Chen, S. W., Hsu, H. H., Tian, Y. C., & Fan, P. C. (2019). Predicting Acute Kidney Injury After Cardiac Surgery. Acta Nephrologica, 33(3), 150-161. https://doi.org/10.6221/AN.201909_33(3).0004
- 黃俊德、吳明儒、陳呈旭（2020）。Acute Kidney Injury: Epidemiology, Clinical Manifestation, Diagnosis, Etiology, Treatment, and Prognosis。腎臟與透析，32(1)，1-5。https://doi.org/10.6340/KD.202003_32(1).0001